TransCode Therapeutics Inc. (RNAZ) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

TransCode Therapeutics In...

NASDAQ: RNAZ · Real-Time Price · USD
10.86
-0.34 (-3.04%)
At close: Sep 12, 2025, 3:56 PM
10.94
0.74%
After-hours: Sep 12, 2025, 07:45 PM EDT

TransCode Therapeutics Revenue

TransCode Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, TransCode Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
7
Market Cap
9.05M

Revenue Chart

History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.